PCMT1 and urinary bladder cancer: By suppressing the production of miR-143-3p and promoting the production of PCMT1, LINC00511s molecular mechanism may prevent bladder cancer cells from proliferating and invading. A novel target for bladder cancer treatment may be offered by LINC00511